Aussies still skipping or rationing medicines
The new cut to the general PBS co-payment is just around the corner – and new data shows Australians need the cash The Pharmacy Guild of Australia has highlighted new …
2025: a year for growth and change – part two
The second part of our look back at the news and events that shaped the profession in 2025 JULY • Pharmacists who have completed relevant training, in both Queensland and …
Sponsors streamline insulin ranges
TGA confirms seven insulin products are set to be discontinued in 2026 Eli Lilly and Novo Nordisk plan to discontinue the supply of some of their insulin products in the second half of …
‘Implement them all’
Government urged to act on all eight recommendations from Deloitte’s Pharmacy Programs Cost Effectiveness Review Consultancy firm Deloitte is calling for the removal of caps on the Home Medicines Review …
Research Roundup
Debbie Rigby rounds up the latest in research news Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity A post hoc analysis of the SURMOUNT-4 trial …
An SSSI for clonidine 150mcg
The TGA has announced that Catapres (clonidine) 150 microgram tablets will be in shortage from December 2025 to April 2026 Clinect has told the Therapeutic Goods Administration that the medicine …
‘This agreement sets a new standard’
Joint initiative safeguards pharmacies following ADHD medicine price change, says Guild Takeda and the Pharmacy Guild of Australia have now reached a collaborative agreement to resolve recent financial challenges faced …
Milestone agreement for pharmacy programs
Government commits to funding medicine reviews as negotiations for the First Pharmacy Programs Agreement (1PPA) gather pace Australians living in rural and remote areas will retain access to pharmacist-delivered care under a …
Wegovy backed for PBS listing
PBAC recommends “risk sharing arrangement” to fund PBS listing of Wegovy for established cardiovascular disease with obesity Pricing could be key for Novo Nordisk to get Wegovy (semaglutide) listed on …
Sigma climbs analyst’s ‘fair value’ ranks
The wholesaler’s merger with Chemist Warehouse saw its value revised by an investment research firm Sigma Healthcare saw the biggest annual jump in ‘fair value’, thanks to its transformational merger …
Docs make submission opposing optometrists’ full scope
Doctors are once again on the attack when it comes to prescribing rights for optometrists, saying they pose “unacceptable” risks The Australian Medical Association has strongly opposed plans by the …
‘That transition process is fraught with risk’
The AJP chats with Advanced Pharmacy Australia’s incoming vice president, Brenda Shum, about transitions of care, the workforce shortage and what matters to her as a pharmacist At AdPha’s recent …